Periodontitis and cardiovascular diseases: Consensus report
By M. Sanz, Álvaro Marco del Castillo, S. Jepsen, J. González-Juanatey, F. D’Aiuto, P. Bouchard, I. Chapple, T. Dietrich, I. Gotsman, F. Graziani and 11 more. Journal of Clinical Periodontology, 2020
1,250 citations recorded by the source corpus.
Abstract Background In Europe cardiovascular disease (CVD) is responsible for 3.9 million deaths (45% of deaths), being ischaemic heart disease, stroke, hypertension (leading to heart failure) the major cause of these CVD related deaths. Periodontitis is also a chronic non‐communicable disease (NCD) with a high prevalence, being severe periodontitis, affecting 11.2% of the world's population, the sixth most common human disease. Material and Methods There is now a significant body of evidence to support independent associations between severe periodontitis and several NCDs, in particular CVD. In 2012 a joint workshop was held between the European Federation of Periodontology (EFP) and the American Academy of Periodontology to review the literature relating periodontitis and systemic diseases, including CVD. In the last five years important new scientific information has emerged providing important emerging evidence to support these associations Results and Conclusions The present review reports the proceedings of the workshop jointly organised by the EFP and the World Heart Federation (WHF), which has updated the existing epidemiological evidence for significant associations between periodontitis and CVD, the mechanistic links and the impact of periodontal therapy on cardiovascular and surrogate outcomes. This review has also focused on the potential risk and complications of periodontal therapy in patients on anti thrombotic therapy and has made recommendations for dentists, physicians and for patients visiting both the dental and medical practices.
Subfields: Oral Surgery, Periodontics, Surgery
View Paper: https://www.semanticscholar.org/paper/c6d159a4380a99e2921a9f7c19ea63ce80e53ee9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Periodontics
Citations in the corpus
- Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline (2020, methodology): “, 2018), cardiovascular diseases (Sanz et al., 2019; Tonetti, Van Dyke, & Working Group 1 of the Joint EFP/AAP Workshop, 2013) or adverse pregnancy outcomes (Sanz, Kornman, & Working Group 3 of Joint EFP/AAP Workshop, 2013).”